Related Experiment Video
Updated: Jun 28, 2025
11:53
Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
7.3K
Copper-mediated siRNA activation for conditional control of gene expression
Kunihiko Morihiro1, Yasuhiro Tomida1, Honami Ando1
1Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Bioorganic & Medicinal Chemistry Letters
|April 9, 2024
Summary
Researchers developed a novel method to activate short interfering RNAs (siRNAs) using copper ions. This copper-responsive gene silencing approach shows promise for targeted cancer therapy by controlling RNA interference.
Area of Science:
- Biochemistry
- Molecular Biology
- Chemical Biology
Background:
- Copper is vital for biological redox balance, with higher concentrations in cancer cells.
- Short interfering RNAs (siRNAs) are potent tools for gene silencing in research and therapeutics.
- Targeted regulation of RNA interference using copper offers potential for cancer-specific therapies.
Purpose of the Study:
- To develop a chemical method for selective siRNA activation triggered by intracellular copper ions.
- To create copper-responsive siRNAs for conditional gene silencing.
- To investigate the potential of metal ion-controlled gene silencing for cancer therapy.
Main Methods:
- Design and synthesis of nucleotides with copper-responsive moieties.
- Incorporation of modified nucleotides into siRNAs.
- Testing the efficacy of copper-responsive siRNAs in silencing target mRNA in living cells.
Main Results:
- Successfully synthesized and incorporated copper-responsive nucleotides into siRNAs.
- Demonstrated effective silencing of cyclin B1 mRNA in living cells using these modified siRNAs.
- Validated the principle of copper-triggered, selective siRNA activation.
Conclusions:
- Introduced a novel chemical approach for conditional gene silencing using intracellular copper ions.
- Expanded the toolkit for chemical knockdown strategies in human cells.
- Paved the way for developing targeted RNA interference therapies for cancer.
More Related Videos
Related Concept Videos
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K